HER2 standards could be unsuitable in determining trastuzumab use in breast cancer patients.

MLA

Burress, Paul. “HER2 Standards Could Be Unsuitable in Determining Trastuzumab Use in Breast Cancer Patients.” Hem/Onc Today, vol. 9, no. 5, Mar. 2008, p. 27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=31672277&authtype=sso&custid=ns315887.

APA

Burress, P. (2008). HER2 standards could be unsuitable in determining trastuzumab use in breast cancer patients. Hem/Onc Today, 9(5), 27.

Chicago

Burress, Paul. 2008. “HER2 Standards Could Be Unsuitable in Determining Trastuzumab Use in Breast Cancer Patients.” Hem/Onc Today 9 (5): 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=31672277&authtype=sso&custid=ns315887.